Accordingly, supplementation of sapienate (partially) and palmitoleate (fully) rescued TMZ+FADS2 or TMZ+SCD inhibition mediated cell death in newly diagnosed GBM cells, while they both fully rescued cell death in recurring GBM cells (Supplementary Figure S11). Here, FADS2 is linked to glioblastoma.